{
  "ticker": "SNY",
  "company_name": "Sanofi",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT02200991",
      "title": "Effect of Lixisenatide on Postprandial Plasma Glucose Compared to Sitagliptin in Combination With Insulin Glargine",
      "status": "COMPLETED",
      "phase": "PHASE4",
      "condition": "Type 2 Diabetes Mellitus",
      "start_date": "2014-08",
      "completion_date": "2015-11",
      "enrollment": 0,
      "sponsor": "Sanofi"
    },
    {
      "nct_id": "NCT01212913",
      "title": "Comparison of Insulin Glargine/Insulin Glulisine Regimen to Insulin Aspart/Insulin Aspart Protamine 30/70 in Type 2 Diabetes Mellitus Patients (T2DM)",
      "status": "COMPLETED",
      "phase": "PHASE4",
      "condition": "Diabetes Mellitus, Type 2",
      "start_date": "2010-08",
      "completion_date": "2012-05",
      "enrollment": 0,
      "sponsor": "Sanofi"
    },
    {
      "nct_id": "NCT03260868",
      "title": "Evaluation of Virtual Versus Traditional Study Conducted in a Group Pilot Study in Adult Patients With Type 1 Diabetes Mellitus (eStudy)",
      "status": "TERMINATED",
      "phase": "PHASE4",
      "condition": "Type 1 Diabetes Mellitus",
      "start_date": "2017-09-19",
      "completion_date": "2018-11-22",
      "enrollment": 0,
      "sponsor": "Sanofi"
    },
    {
      "nct_id": "NCT04180488",
      "title": "Dupilumab for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are na\u00efve to, Intolerant of, or Incomplete Responders to Omalizumab (LIBERTY-CSU CUPID)",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Chronic Spontaneous Urticaria",
      "start_date": "2019-12-11",
      "completion_date": "2024-10-25",
      "enrollment": 0,
      "sponsor": "Sanofi"
    },
    {
      "nct_id": "NCT04113330",
      "title": "Surveillance of Suspected Dengue Cases for Access to Care for Subjects Identified as Seronegative or Undetermined Before Receiving CYD Dengue Vaccine in Previous Clinical Studies in Colombia",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "",
      "condition": "Dengue Fever",
      "start_date": "2020-01-31",
      "completion_date": "2028-07-15",
      "enrollment": 0,
      "sponsor": "Sanofi Pasteur, a Sanofi Company"
    },
    {
      "nct_id": "NCT00142467",
      "title": "Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Hepatocellular Carcinoma",
      "start_date": "2004-04",
      "completion_date": "2011-06",
      "enrollment": 0,
      "sponsor": "Massachusetts General Hospital"
    },
    {
      "nct_id": "NCT03132636",
      "title": "PD-1 in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Carcinoma, Basal Cell",
      "start_date": "2017-06-29",
      "completion_date": "2023-04-27",
      "enrollment": 0,
      "sponsor": "Regeneron Pharmaceuticals"
    },
    {
      "nct_id": "NCT00592306",
      "title": "Intraoperative Versus Postoperative Thymoglobulin in Lung Transplantation",
      "status": "WITHDRAWN",
      "phase": "PHASE3",
      "condition": "Lung Transplant",
      "start_date": "2006-01",
      "completion_date": "2010-09",
      "enrollment": 0,
      "sponsor": "University of California, Los Angeles"
    },
    {
      "nct_id": "NCT02057250",
      "title": "To Evaluate Sarilumab - SAR153191 (REGN88) - Auto-injector Device In Patients With Rheumatoid Arthritis",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "RA",
      "start_date": "2014-03",
      "completion_date": "2016-03",
      "enrollment": 0,
      "sponsor": "Sanofi"
    },
    {
      "nct_id": "NCT00526110",
      "title": "Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction Patients",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "Gastrointestinal Diseases",
      "start_date": "2004-08",
      "completion_date": "2015-06",
      "enrollment": 0,
      "sponsor": "M.D. Anderson Cancer Center"
    }
  ],
  "summary": {
    "total_trials": 50,
    "by_phase": {
      "PHASE4": 6,
      "PHASE3": 9,
      "": 7,
      "PHASE2": 8,
      "PHASE1, PHASE2": 7,
      "NA": 2,
      "PHASE1": 10,
      "PHASE2, PHASE3": 1
    },
    "by_status": {
      "COMPLETED": 38,
      "TERMINATED": 5,
      "ACTIVE_NOT_RECRUITING": 2,
      "WITHDRAWN": 1,
      "UNKNOWN": 3,
      "RECRUITING": 1
    },
    "active_trials": 3,
    "completed_trials": 38,
    "conditions": [
      "Acute Lymphoblastic Leukemia",
      "Acute Myeloid Leukemia",
      "Atopic Dermatitis",
      "Carcinoma, Basal Cell",
      "Carcinoma, Hepatocellular",
      "Chlamydia Trachomatis",
      "Chronic Spontaneous Urticaria",
      "Dengue Fever",
      "Diabetes Mellitus, Type 2",
      "Diabetes Mellitus, Type 2, Primary Care",
      "Diabetes Mellitus, Type I",
      "Diffuse Large Cell Lymphoma",
      "Fabry",
      "Follicular Lymphoma, Marginal Zone Lymphoma, Mantle Cell Lymphoma, Small Lymphocytic Lymphoma, Lymphoplasmacytic Lymphoma, Low Grade B-cell Lymphoma, Not Otherwise Specified, Diffuse Large B-cell Lymphoma, Peripheral T-cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Anaplastic Large-cell Lymphoma",
      "Gastrointestinal Diseases",
      "Healthy",
      "Hemodialysis",
      "Hepatitis B",
      "Hepatocellular Carcinoma",
      "Hypertension",
      "Lung Transplant",
      "Macular Degeneration, Age-Related Maculopathies, Age-Related Maculopathy, Maculopathies, Age-Related, Maculopathy, Age-Related, Retinal Degeneration, Retinal Neovascularization, Gene Therapy, Therapy, Gene, Eye Diseases",
      "Meningitis, Meningococcal Infection, Diphtheria, Tetanus, Pertussis, Haemophilus Influenzae Serotype b (Hib)",
      "Meningitis, Meningococcal Meningitis, Meningococcal Infections",
      "Metastatic Melanoma",
      "Metastatic Pancreatic Cancer",
      "Neoplasm Malignant",
      "Peripheral T-cell Lymphomas",
      "Pertussis, Diphtheria",
      "Pneumococcal Infections, Pneumococcal Pneumonia",
      "Polycystic Kidney, Autosomal Dominant",
      "Pompe Disease",
      "RA",
      "Relapsed Cancer, Refractory Multiple Myeloma, Multiple Myeloma",
      "Renal Transplantation, Immunosuppression",
      "Rheumatoid Arthritis",
      "Solid Tumors",
      "Sphingomyelin Lipidosis",
      "Squamous Cell Carcinoma of Head and Neck, Non-small Cell Lung Cancer, Hepatocellular Carcinoma, Esophageal Cancer, Gastric Cancer, Melanoma, Renal Cell Carcinoma, Pancreatic Cancer, Cervical Cancer, Triple Negative Breast Cancer, Advanced Cancer, Metastatic Cancer",
      "Thrombotic Thrombocytopenic Purpura",
      "Tonsillitis, Pharyngitis",
      "Trypanosomiasis, African, Sleeping Sickness, Trypanosomiasis; Gambian",
      "Type 1 Diabetes Mellitus",
      "Type 2 Diabetes",
      "Type 2 Diabetes Mellitus",
      "Type 2 Diabetes, Hyperglycemia",
      "Venous Thromboembolism"
    ],
    "lead_stage": "commercial"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:22:00.044713",
    "search_query": "Sanofi",
    "url": "https://clinicaltrials.gov/search?term=Sanofi"
  }
}